Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

About this update from Organigram Global Inc.

Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting .bwalignc { text-align: center; list-style-position: inside } .bwalignl { text-align: left } .bwblockalignl { margin-left: 0px; margin-right: auto } .bwcellpmargin { margin-bottom: 0px; margin-top: 0px } .bwleftsingle { border-left: solid black 1pt } .bwlistdisc { list-style-type: disc } .bwpadb3 { padding-bottom: 4px } .bwpadl1 { padding-left: 5px } .bwpadr0 { padding-right: 0px } .bwrightsingle { border-right: solid black 1pt } .bwsinglebottom { border-bottom: solid black 1pt } .bwtablemarginb { margin-bottom: 10px } .bwtopsingle { border-top: solid black 1pt } .bwvertalignt { vertical-align: top } .bwwidth100 { width: 100% } .bwwidth17 { width: 17% } .bwwidth32 { width: 32% } Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the “ Transaction ”) of Sanity Group GmbH (“ Sanity Group ”) and the related private placement financing (the “ Private Placement ”) with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco (“ BAT ”) at the Company’s annual general and special meeting of shareholders (the “ Shareholders ”) held on March 30, 2026 (the “ Meeting ”). Shareholders approved an ordinary resolution (the “ Transaction Resolution ”) authorizing (i) the indirect acquisition by the Company of all the issued and outstanding shares of Sanity Group not already owned by the Company, and (ii) the issuance by the Company of up to 96,287,602 common shares to the shareholders of Sanity Group and BAT in connection with the Transaction and the Private Placement, by an affirmative vote of 93% of the votes represented at the Meeting, excluding the votes attached to the Company’s common shares beneficially owned, or over which control or direction was exercised by BAT, its associates and affiliates and their respective directors and officers who held Organigram common shares as of the record date for the Meeting in accordance with the rules of the TSX Company Manual an...

View stock analysis, news, and events for Organigram Global Inc.